Internet Journal of Emerging Medical Technologies

Visit Medgadget

Neuronetics TMS Depression Therapy Gets FDA OK

Posted on October 09, 2008

Neuronetics, a Malvern, Pennsylvania company, has won FDA's first approval for a transcranial magnetic stimulation (TMS) system for treatment of depression in patients that don't respond to drug therapy. This is a huge step for a technology we've been following for many years now. Deep TMS devices are thought not only to help with depression, but one day might be indicated for schizophrenia, migranes, and restoration of peripheral vision for patients who are status post stroke. NeuroStar TMS Therapy is specifically indicated for the treatment of Major Depressive Disorder in adult patients wh...

Original article link


antidepressant , anxiety , depression , schizophrenia , stroke